Clinical trials: Vulvovaginal Atrophy

Vaginal Atrophy

Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy

• Completed
• Age: 40 to 80 years
• Phase 2
• Results posted

A Phase 2, Dose-ranging, 12-week Randomized, Double-blind, Placebo controlled, Parallel-group Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005% Estriol Vaginal Gel…

Trial name

NCT02967510

Testing

Estriol

Where

23 sites in Czechia, Hungary and 3 more

Volunteers

283 people

Sponsor

ITF Research Pharma, S.L.U.